Entrada Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $614k | 106k | 5.80 |
| 2025-06-30 | $659k | 98k | 6.72 |
| 2025-03-31 | $905k | 100k | 9.04 |
| 2024-12-31 | $1.8M | 101k | 17.29 |
| 2024-09-30 | $1.7M | 105k | 15.98 |
| 2024-06-30 | $1.8M | 125k | 14.25 |
| 2024-03-31 | $1.6M | 111k | 14.17 |
| 2023-12-31 | $1.7M | 115k | 15.09 |
| 2023-09-30 | $1.1M | 67k | 15.80 |
| 2023-06-30 | $1.0M | 66k | 15.14 |
| 2023-03-31 | $180k | 12k | 14.50 |
| 2022-12-31 | $168k | 12k | 13.52 |
| 2022-03-31 | $206k | 22k | 9.39 |
| 2021-12-31 | $234k | 14k | 17.14 |